Medical Stop-Loss Premiums Rise 11.5% For Self-Funded Plans

Expensive specialty drugs and ordinary severe claims are pushing the cost of protecting a self-funded employer health plan against catastrophic risk higher.

For self-funded plans that kept their deductibles the same, the average premium for medical stop-loss insurance has increased 11.5% this year, down from 13.4% in 2023,  according to the Segal Group, a New York-based benefits and compensation consulting firm.

Beccause employers often hold down stop-loss increases by moving to higher deductibles, the amount employers really paid for stop-loss coverage, after taking the deductible changes into account, increased 9.4% this year, up from 8.4% last year.

Segal analysts based the 2024 figures on records for 234 health plans with an average of 2,300 participants per plan.

A stop-loss policy can pay benefits when the cost for an entire plan or the cost for a specific participant reaches a minimum level.

Price increases have been harder on stop-loss users that have tried to save money by accepting higher specific participant deductibles. For plans that cut costs by setting the annual deductible at $500,000 per plan participant, the median premiums increased 29%, to $40 per participant per month.

For plans with a specific deductible of $200,000, the median premium increased only 7.1%, to $93 per participant per month.

 

Source Link

Recommended Articles

Trump Says He May Veto Extension of Health Care Subsidies

President Donald Trump said Sunday he may veto a bill to extend Obamacare subsidies if Congress sent one to his desk. Trump’s remark to reporters on Air Force Once comes after nine swing-district House Republicans joined Democrats Wednesday in advancing legislation to revive expired Affordable Care Act subsidies for three years. The Senate has yet to vote ...

Read More

Trump’s Plan To Strong-Arm Insurers Into Lower Prices Is Met With Skepticism

There are reasons to be skeptical that voluntary cuts by insurance companies could bring significant, lasting health care savings for Americans.

Read More

AbbVie To Cut Drug Prices, Pledges $100 Billion For Research

AbbVie (ABBV.N), opens new tab said on Monday that it has struck a three-year deal with U.S. President Donald Trump’s administration to reduce drug prices, and has pledged $100 billion over the next decade for research and development in the country. The drugmaker said the investment will include manufacturing and will expand direct-to-patient offerings through TrumpRx for ...

Read More

Dems Make Health Deal Offer With ACA Subsidies

Democrats sent Republicans a proposal over the weekend to renew enhanced Affordable Care Act subsidies for three years, paired with extensions of other expiring health programs, sources said. Why it matters: Sunday’s offer shows there’s increasing bipartisan sentiment to address long-stalled priorities like overhauling pharmacy benefit manager business practices — even if prospects for the ACA subsidies ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square